Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Survey of current prophylaxis practices and bleeding characteristics of children with severe haemophilia A in US haemophilia treatment centres.

Ragni MV, Fogarty PJ, Josephson NC, Neff AT, Raffini LJ, Kessler CM.

Haemophilia. 2012 Jan;18(1):63-8. doi: 10.1111/j.1365-2516.2011.02554.x.

PMID:
21539695
2.
3.

Optimizing factor prophylaxis for the haemophilia population: where do we stand?

Blanchette VS, Manco-Johnson M, Santagostino E, Ljung R.

Haemophilia. 2004 Oct;10 Suppl 4:97-104. Review.

PMID:
15479380
4.

The overall effectiveness of prophylaxis in severe haemophilia.

Panicker J, Warrier I, Thomas R, Lusher JM.

Haemophilia. 2003 May;9(3):272-8.

PMID:
12694517
5.

A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres.

Blanchette VS, McCready M, Achonu C, Abdolell M, Rivard G, Manco-Johnson MJ.

Haemophilia. 2003 May;9 Suppl 1:19-26; discussion 26.

PMID:
12709033
6.

Factor VIII prophylaxis for adult patients with severe haemophilia A: results of a US survey of attitudes and practices.

Walsh CE, Valentino LA.

Haemophilia. 2009 Sep;15(5):1014-21. doi: 10.1111/j.1365-2516.2009.02036.x.

PMID:
19493018
7.

The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.

Biss TT, Chan AK, Blanchette VS, Iwenofu LN, McLimont M, Carcao MD; Association of Hemophilia Clinic Directors of Canada (AHCDC).; Canadian Association of Nurses in Hemophilia Care (CANHC)..

Haemophilia. 2008 Sep;14(5):923-30. doi: 10.1111/j.1365-2516.2008.01810.x.

PMID:
18637844
8.

Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.

Fischer K, Valentino L, Ljung R, Blanchette V.

Haemophilia. 2008 Jul;14 Suppl 3:196-201. doi: 10.1111/j.1365-2516.2008.01736.x.

PMID:
18510542
9.

Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study.

Feldman BM, Pai M, Rivard GE, Israels S, Poon MC, Demers C, Robinson S, Luke KH, Wu JK, Gill K, Lillicrap D, Babyn P, McLimont M, Blanchette VS; Association of Hemophilia Clinic Directors of Canada Prophylaxis Study Group..

J Thromb Haemost. 2006 Jun;4(6):1228-36.

10.

Experience of prophylaxis treatment in children with severe haemophilia.

Yee TT, Beeton K, Griffioen A, Harrington C, Miners A, Lee CA, Brown SA.

Haemophilia. 2002 Mar;8(2):76-82.

PMID:
11952841
11.

The treatment of haemophilia, including prophylaxis, constant infusion and DDAVP.

Berntorp E.

Baillieres Clin Haematol. 1996 Jun;9(2):259-71. Review.

PMID:
8800504
12.

When should prophylactic treatment in patients with haemophilia A and B start?--The German experience.

Kreuz W, Escuriola-Ettingshausen C, Funk M, Schmidt H, Kornhuber B.

Haemophilia. 1998 Jul;4(4):413-7.

PMID:
9873763
14.

Current situation of regular replacement therapy (prophylaxis) for haemophilia in Japan.

Taki M, Shirahata A.

Haemophilia. 2009 Jan;15(1):78-82. doi: 10.1111/j.1365-2516.2008.01823.x.

PMID:
18700841
15.

Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A.

Risebrough N, Oh P, Blanchette V, Curtin J, Hitzler J, Feldman BM.

Haemophilia. 2008 Jul;14(4):743-52. doi: 10.1111/j.1365-2516.2008.01664.x.

PMID:
18422610
16.

Primary prophylaxis in children with haemophilia.

Coppola A, Di Capua M, De Simone C.

Blood Transfus. 2008 Sep;6 Suppl 2:s4-11. Review.

17.
18.
19.

U.S. survey of surgical capabilities and experience with surgical procedures in patients with congenital haemophilia with inhibitors.

Shapiro A, Cooper DL.

Haemophilia. 2012 May;18(3):400-5. doi: 10.1111/j.1365-2516.2011.02698.x.

PMID:
22168829
20.

Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey.

Zappa S, McDaniel M, Marandola J, Allen G.

Haemophilia. 2012 May;18(3):e140-53. doi: 10.1111/j.1365-2516.2012.02770.x.

PMID:
22533455
Items per page

Supplemental Content

Support Center